Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Lonza announced the completion of a laboratory expansion at its active pharmaceutical ingredients (API) manufacturing site at Nansha, China. The expansion focused on extending the capabilities and capacity of development laboratories and kilogram-...
read more
Monday, September 09, 2024
Hongene Biotech Corporation, a nucleic acid manufacturing company, and ReciBioPharm, an advanced therapeutics CDMO services provider, have announced a strategic collaboration that will enhance gene editing drug manufacturing capabilities.
read more
Juno Therapeutics, a biopharmaceutical company focused on re-engaging the body's immune system to revolutionize the treatment of cancer, and WuXi AppTec, an open-access R&D capability and technology platform company serving the pharmaceutical, ...
read more
Delavau Pharmaceutical Partners has welcomed industry veteran Curt Pagano to its team as the Vice President of Quality and Regulatory.
read more
Frontage Laboratories has established a joint venture with Zhejiang Jiuzhou Pharmaceutical Co., Ltd. to provide enhanced access to high quality and economical API & intermediate development and manufacturing (CDMO) services to new US clients focused ...
read more
Pharmaceutical Product Development, LLC (PPD) has announced that Bruce Stouffer has joined PPD as executive director of immunochemistry in the PPD® Laboratories’ bioanalytical lab.
read more
Wednesday, March 22, 2023
Hovione and Laxxon Medical announced a collaboration to advance the use of 3D screen printing technologies for the pharma industry.
read more
Oncodesign Services and Veritas In Silico Inc have entered into a Memorandum of Understanding (“MOU”) to respond to the needs of pharmaceutical companies seeking to develop innovative small molecule drugs targeting messenger RNA (“mRNA”).
read more
Tuesday, December 02, 2025
WuXi Biologics announced that it has signed a strategic Memorandum of Understanding (MoU) with the Qatar Free Zones Authority (QFZ) to extend WuXi Biologics' global network and capabilities to the Middle East.
read more
Thursday, August 01, 2013
In June 2013, Almac, a leading provider of contract services to the global Pharmaceutical and Biotech industries, hosted Otsuka America Pharmaceutical Inc.’s (OAPI) Clinical Trial Supply team at Almac’s North American Headquarters in Souderton, PA. ...
read more
Epic Sciences announced today an agreement with Laboratory Corporation of America® Holdings to provide circulating tumor cell (CTC) technology and support oncology clinical trials in Asia through Covance Drug Development
read more
Scinai Immunotherapeutics has completed a strategic corporate reorganization that establishes a dedicated contract development and manufacturing organization (CDMO) subsidiary and a leaner research and development operation.
read more
CAPS® held a ribbon cutting ceremony for its new sterile compounding outsourcing facility in Phoenix, AZ, bringing nearly 400 jobs to the area.
read more
Wednesday, April 16, 2014
Marken announced today the completion of an industry wide, independent market research study. The survey included 250 key decision makers of clinical trial logistics services from pharmaceutical companies, central laboratories, clinical research ...
read more
Wednesday, September 10, 2025
GBI Biomanufacturing (GBI) announced a partnership with NanoRetinal, Inc. to develop and manufacture NAR-001, NanoRetinal's proprietary nanoparticle technology designed to restore and/or preserve vision in patients with Inherited Retinal Diseases (...
read more